Catalyst Wire Dossier Catalyst Wire Dossier

Symbioflor 2

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Symbioflor 2, covering 2017-06-23 to 2017-06-23. Get the full timeline:

Most recent: EMA recommends that Symbioflor 2 can continue to be used for irritable bowel syndrome

See pricing